메뉴 건너뛰기




Volumn 55, Issue 9, 2006, Pages 1224-1225

Tacrolimus - Finally!

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; INFLIXIMAB; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NATALIZUMAB; PLACEBO; PURINE DERIVATIVE; STEROID; TACROLIMUS; VISILIZUMAB;

EID: 33747773067     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.093302     Document Type: Note
Times cited : (6)

References (25)
  • 1
    • 33747790601 scopus 로고    scopus 로고
    • A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
    • Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 2006;55:1255-62.
    • (2006) Gut , vol.55 , pp. 1255-1262
    • Ogata, H.1    Matsui, T.2    Nakamura, M.3
  • 2
    • 0032447773 scopus 로고    scopus 로고
    • Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus
    • Fellermann K, Ludwig D, Stahl M, et al. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus. Am J Gastroenterol 1998;93:1860-6.
    • (1998) Am J Gastroenterol , vol.93 , pp. 1860-1866
    • Fellermann, K.1    Ludwig, D.2    Stahl, M.3
  • 3
    • 0036743048 scopus 로고    scopus 로고
    • Response of refractory colitis to intravenous or oral tacrolimus (FK506)
    • Fellermann K, Tanko Z, Herrlinger KR, et al. Response of refractory colitis to intravenous or oral tacrolimus (FK506). Inflamm Bowel Dis 2002;8:317-24.
    • (2002) Inflamm Bowel Dis , vol.8 , pp. 317-324
    • Fellermann, K.1    Tanko, Z.2    Herrlinger, K.R.3
  • 4
    • 0038620355 scopus 로고    scopus 로고
    • Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease
    • Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:1273-81.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 1273-1281
    • Baumgart, D.C.1    Wiedenmann, B.2    Dignass, A.U.3
  • 5
    • 29244457275 scopus 로고    scopus 로고
    • Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
    • Ardizzone S, Maconi G, Russo A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006;55:47-53.
    • (2006) Gut , vol.55 , pp. 47-53
    • Ardizzone, S.1    Maconi, G.2    Russo, A.3
  • 6
    • 0028292007 scopus 로고
    • Cyclosporine in severe ulcerative colitis refractory to steroid therapy
    • Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
    • (1994) N Engl J Med , vol.330 , pp. 1841-1845
    • Lichtiger, S.1    Present, D.H.2    Kornbluth, A.3
  • 7
    • 0035045816 scopus 로고    scopus 로고
    • Intravenous cyclopsorine versus intravenous corticosteroids as single therapy of severe attacks of ulcerative colitis
    • D'Haens G, Lemmens L, Geboes K, et al. Intravenous cyclopsorine versus intravenous corticosteroids as single therapy of severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.
    • (2001) Gastroenterology , vol.120 , pp. 1323-1329
    • D'Haens, G.1    Lemmens, L.2    Geboes, K.3
  • 8
    • 10744231879 scopus 로고    scopus 로고
    • Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis
    • van Assche G, D'Haens G, Noman M, et al. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025-31.
    • (2003) Gastroenterology , vol.125 , pp. 1025-1031
    • Van Assche, G.1    D'Haens, G.2    Noman, M.3
  • 9
    • 0032201035 scopus 로고    scopus 로고
    • Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: An open-label retrospective trial
    • Actis GC, Aimo G, Priolo G, et al. Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998;4:276-9.
    • (1998) Inflamm Bowel Dis , vol.4 , pp. 276-279
    • Actis, G.C.1    Aimo, G.2    Priolo, G.3
  • 10
    • 0030482294 scopus 로고    scopus 로고
    • Intravenous cyclosporine in attacks of ulcerative colitis
    • Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis. Dig Dis Sci 1996;41:2471-6.
    • (1996) Dig Dis Sci , vol.41 , pp. 2471-2476
    • Carbonnel, F.1    Boruchowicz, A.2    Duclos, B.3
  • 11
    • 0030015532 scopus 로고    scopus 로고
    • Predicting outcome in severe ulcerative colitis
    • Travis SPL, Farrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905-10.
    • (1996) Gut , vol.38 , pp. 905-910
    • Travis, S.P.L.1    Farrant, J.M.2    Ricketts, C.3
  • 12
    • 1542619846 scopus 로고    scopus 로고
    • Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis
    • Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004;10:73-8.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 73-78
    • Arts, J.1    D'Haens, G.2    Zeegers, M.3
  • 13
    • 12344329448 scopus 로고    scopus 로고
    • Ciclosporin use in acute ulcerative colitis: A long-term experience
    • Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol 2005;17:79-84.
    • (2005) Eur J Gastroenterol Hepatol , vol.17 , pp. 79-84
    • Campbell, S.1    Travis, S.2    Jewell, D.3
  • 14
    • 0033070414 scopus 로고    scopus 로고
    • A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin
    • Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5:1-10.
    • (1999) Inflamm Bowel Dis , vol.5 , pp. 1-10
    • Cohen, R.D.1    Brodsky, A.L.2    Hanauer, S.B.3
  • 15
    • 0001902429 scopus 로고
    • A critical review of cyclosporine therapy in inflammatory bowel disease
    • Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995;1:48-63.
    • (1995) Inflamm Bowel Dis , vol.1 , pp. 48-63
    • Sandborn, W.J.1
  • 16
    • 0038460945 scopus 로고    scopus 로고
    • Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: A randomised controlled trial
    • Probert CS, Hearing SD, Schreiber S, et al. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut 2003;52:998-1002.
    • (2003) Gut , vol.52 , pp. 998-1002
    • Probert, C.S.1    Hearing, S.D.2    Schreiber, S.3
  • 17
    • 20444479336 scopus 로고    scopus 로고
    • Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study
    • Jarnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005;128:1805-11.
    • (2005) Gastroenterology , vol.128 , pp. 1805-1811
    • Jarnerot, G.1    Hertervig, E.2    Friis-Liby, I.3
  • 18
    • 28844473957 scopus 로고    scopus 로고
    • Infliximab for induction and maintenance therapy for ulcerative colitis
    • Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
    • (2005) N Engl J Med , vol.353 , pp. 2462-2476
    • Rutgeerts, P.1    Sandborn, W.J.2    Feagan, B.G.3
  • 19
    • 0347991877 scopus 로고    scopus 로고
    • The safety profile of infliximab in patients with Crohn's disease: The Mayo clinic experience in 500 patients
    • Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
    • (2004) Gastroenterology , vol.126 , pp. 19-31
    • Colombel, J.F.1    Loftus Jr., E.V.2    Tremaine, W.J.3
  • 20
    • 2442696315 scopus 로고    scopus 로고
    • Infliximab in inflammatory bowel disease: Clinical outcome in a population based cohort from Stockholm County
    • Ljung T, Karlen P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004;53:849-53.
    • (2004) Gut , vol.53 , pp. 849-853
    • Ljung, T.1    Karlen, P.2    Schmidt, D.3
  • 21
    • 0037372956 scopus 로고    scopus 로고
    • Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease
    • Stallmach A, Wittig BM, Moser C, et al. Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. Gut 2003;52:377-82.
    • (2003) Gut , vol.52 , pp. 377-382
    • Stallmach, A.1    Wittig, B.M.2    Moser, C.3
  • 22
    • 0038115119 scopus 로고    scopus 로고
    • Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy
    • Prajapati DN, Knox JF, Emmons J, et al. Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. J Clin Gastroenterol 2003;37:125-8.
    • (2003) J Clin Gastroenterol , vol.37 , pp. 125-128
    • Prajapati, D.N.1    Knox, J.F.2    Emmons, J.3
  • 23
    • 0033950428 scopus 로고    scopus 로고
    • Mycophenolate mofetil: Lack of efficacy in chronic active inflammatory bowel disease
    • Fellermann K, Steffen M, Stein J, et al. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:171-6.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 171-176
    • Fellermann, K.1    Steffen, M.2    Stein, J.3
  • 24
    • 0034064823 scopus 로고    scopus 로고
    • Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: A 12-month pilot study
    • Orth T, Peters M, Schlaak JF, et al. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study. Am J Gastroenterol 2000;95:1201-7.
    • (2000) Am J Gastroenterol , vol.95 , pp. 1201-1207
    • Orth, T.1    Peters, M.2    Schlaak, J.F.3
  • 25
    • 0033003888 scopus 로고    scopus 로고
    • Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
    • Neurath MF, Wanitschke R, Peters M, et al. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999;44:625-8.
    • (1999) Gut , vol.44 , pp. 625-628
    • Neurath, M.F.1    Wanitschke, R.2    Peters, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.